MADRIGAL PHARMACEUTICALS, INC. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2017-08-21

Reporting Person: Levy Richard S (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-21	Common Stock	P	900	$15.67	Acquired	900	Direct
2017-08-21	Common Stock	P	100	$15.70	Acquired	1000	Direct
2017-08-21	Common Stock	P	100	$15.72	Acquired	1100	Direct
2017-08-21	Common Stock	P	200	$15.77	Acquired	1300	Direct
2017-08-21	Common Stock	P	200	$15.79	Acquired	1500	Direct
2017-08-21	Common Stock	P	400	$15.80	Acquired	1900	Direct
2017-08-21	Common Stock	P	10	$15.90	Acquired	1910	Direct
2017-08-21	Common Stock	P	200	$15.93	Acquired	2110	Direct
2017-08-21	Common Stock	P	200	$16.02	Acquired	2310	Direct
2017-08-21	Common Stock	P	210	$16.04	Acquired	2520	Direct
2017-08-21	Common Stock	P	440	$16.07	Acquired	2960	Direct
2017-08-21	Common Stock	P	590	$16.09	Acquired	3550	Direct